DAZATRO Trademark

Trademark Overview

On Wednesday, December 10, 2014, a trademark application was filed for DAZATRO with the United States Patent and Trademark Office. The USPTO has given the DAZATRO trademark a serial number of 86476339. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 16, 2025. This trademark is owned by Glaxo Group Limited. The DAZATRO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

General Information

Serial Number86476339
Word MarkDAZATRO
Filing DateWednesday, December 10, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 16, 2025
Registration Number5598254
Registration DateTuesday, November 6, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 16, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Thursday, March 19, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 13, 2014NEW APPLICATION ENTERED
Monday, December 15, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 18, 2015ASSIGNED TO EXAMINER
Friday, April 10, 2015ASSIGNED TO LIE
Friday, April 10, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 19, 2015PUBLISHED FOR OPPOSITION
Tuesday, May 19, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 21, 2015SOU EXTENSION 1 GRANTED
Tuesday, July 14, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 21, 2015SOU TEAS EXTENSION RECEIVED
Monday, December 21, 2015SOU EXTENSION 1 FILED
Wednesday, December 23, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 29, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, June 29, 2016SOU EXTENSION 2 FILED
Friday, July 29, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 5, 2016SOU EXTENSION 2 GRANTED
Saturday, August 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 6, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, December 6, 2016SOU EXTENSION 3 FILED
Sunday, December 18, 2016SOU EXTENSION 3 GRANTED
Tuesday, December 20, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 11, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2017SOU EXTENSION 4 FILED
Tuesday, July 11, 2017SOU EXTENSION 4 GRANTED
Thursday, July 13, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2017SOU TEAS EXTENSION RECEIVED
Tuesday, November 14, 2017SOU EXTENSION 5 FILED
Saturday, November 18, 2017SOU EXTENSION 5 GRANTED
Tuesday, November 21, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 15, 2018TEAS PETITION TO AMEND BASIS RECEIVED
Tuesday, July 10, 2018ASSIGNED TO PETITION STAFF
Friday, July 13, 2018PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Monday, July 16, 2018NOTICE OF ALLOWANCE CANCELLED
Monday, July 16, 20181(B) BASIS DELETED; NEW BASIS REQUESTED
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 6, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 6, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, May 16, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

dazatro pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological